electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018)
electroCore (ECOR) recorded quarterly Non-Current Deffered Revenue of $245632.0 in Q4 2018, down 6.42% quarter-over-quarter from $262497.0 in Q3 2018, and down 19.96% on a YoY basis from $306886.0 in Q4 2017.
electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
electroCore's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $245632.0 for Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue fell 19.96% year-over-year to $245632.0; the TTM figure through Dec 2018 stood at $245632.0 (down 19.96% YoY), while the FY2018 annual figure was $245632.0, down 19.96% from the prior year.
- Non-Current Deffered Revenue was $245632.0 for Q4 2018 at electroCore, down from $262497.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $306886.0 in Q4 2017 to a low of $245632.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | electroCore | 75,742.38 | -8.80 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 245,632.00 |
| Sep 30, 2018 | 262,497.00 |
| Jun 30, 2018 | 279,362.00 |
| Dec 31, 2017 | 306,886.00 |